# Kolmar Korea Co. Ltd. - Gwanjeong 2 Branch – FDA Inspection, Jul 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/kolmar-korea-co-ltd-gwanjeong-2-branch/3132fde3-f08f-42bf-b3b6-19baa40715a1
Source feed: FDA_Inspections

> FDA inspection 1214366 of Kolmar Korea Co. Ltd. - Gwanjeong 2 Branch, July 21, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1214366
- Company Name: Kolmar Korea Co. Ltd. - Gwanjeong 2 Branch
- Inspection Date: 2023-07-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Lata C. Mathew](https://www.keypedia.com/people/lata-c-mathew/0610a0ef-dcc5-43e7-ab74-2ac54d758beb)

Company: https://www.keypedia.com/companies/kolmar-korea-co-ltd-gwanjeong-2-branch/c52e6ae2-a4d5-46e1-8cf9-bbe164bec487

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c